In this study, the anti-tumor activity was assessed using one tumor model, MC38, however, mouse specific 4-1BB antibodies have been evaluated in numerous preclinical tumor models and demonstrated synergistic activity with many therapies [39, 49]. The gene discussed is TNFRSF9; the disease is neoplasm.